Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers
Mutations in β-cardiac myosin, the predominant motor protein for human heart contraction, can alter power output and cause cardiomyopathy. However, measurements of the intrinsic force, velocity, and ATPase activity of myosin have not provided a consistent mechanism to link mutations to muscle pathol...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 115; no. 35; pp. E8143 - E8152 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
28.08.2018
|
Series | PNAS Plus |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Mutations in β-cardiac myosin, the predominant motor protein for human heart contraction, can alter power output and cause cardiomyopathy. However, measurements of the intrinsic force, velocity, and ATPase activity of myosin have not provided a consistent mechanism to link mutations to muscle pathology. An alternative model posits that mutations in myosin affect the stability of a sequestered, super relaxed state (SRX) of the protein with very slow ATP hydrolysis and thereby change the number of myosin heads accessible to actin. Here we show that purified human β-cardiac myosin exists partly in an SRX and may in part correspond to a folded-back conformation of myosin heads observed in muscle fibers around the thick filament backbone. Mutations that cause hypertrophic cardiomyopathy destabilize this state, while the small molecule mavacamten promotes it. These findings provide a biochemical and structural link between the genetics and physiology of cardiomyopathy with implications for therapeutic strategies. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 AC02-06CH11357; GM33289; HL117138; AR062279; HL084553; P41 GM103622 National Institutes of Health (NIH) USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities Division Edited by Thomas D. Pollard, Yale University, New Haven, CT, and approved July 19, 2018 (received for review June 5, 2018) Author contributions: R.L.A., D.V.T., S.S.S., K.M.R., T.C.I., R.C., E.M.G., and J.A.S. designed research; R.L.A., D.V.T., S.S.S., M.H., W.M., H.G., J.G., F.L.W., M.M.M., K.M.R., R.C., E.M.G., and J.A.S. performed research; R.L.A., D.V.T., S.S.S., M.H., W.M., H.G., C.S.R., J.G., F.L.W., M.M.M., J.G.S., K.M.R., T.C.I., R.C., E.M.G., and J.A.S. contributed new reagents/analytic tools; R.L.A., D.V.T., S.S.S., M.H., W.M., H.G., J.G., F.L.W., M.M.M., J.G.S., K.M.R., T.C.I., R.C., E.M.G., and J.A.S. analyzed data; and R.L.A., D.V.T., S.S.S., K.M.R., T.C.I., R.C., E.M.G., and J.A.S. wrote the paper. 1R.L.A., D.V.T., and S.S.S. contributed equally to this work. 2E.M.G. and J.A.S. contributed equally to this work. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1809540115 |